col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


143 Results       Page 1

 [1] 
Springer-Verlag: Clinical Rheumatology
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―14 A rare twist: COVID-19 infection masquerading as IgA vasculitis in a hemophilia a patient Khalid A. Alnaqbi, Nasser Abunamous, Tausif Saleem
2 [GO] 2024―Jan―29 The effect of COVID-19 infection on patients with rheumatic diseases in China Peng Lai, Haifeng Chen, Yunxia Yan, Mengru Du, Zhiling Zhao, Dandan Wang, et al. (+4)
3 [GO] 2023―Sep―21 Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases Charalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, Nafsika Gerolymatou, Eleni Kalavri, Christos Bounos, et al. (+27)
4 [GO] 2023―Aug―08 Patient perspectives on telemedicine use in rheumatology during the COVID-19 pandemic: survey results from the COVID-19 Global Rheumatology Alliance Mithu Maheswaranathan, Bruce Miller, Natasha Ung, Rashmi Sinha, Carly Harrison, Bugra Han Egeli, et al. (+5)
5 [GO] 2023―Jul―08 New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome Prakashini MV, Akerke Auanassova, Marlen Yessirkepov, Olena Zimba, Armen Yuri Gasparyan, George D. Kitas, Sakir Ahmed
6 [GO] 2023―Jul―05 Correction to: Incident autoimmune diseases in association with SARS-CoV-2 infection: A matched cohort study Falko Tesch, Franz Ehm, Annika Vivirito, Danny Wende, Manuel Batram, Friedrich Loser, et al. (+18)
7 [GO] 2023―Jun―19 Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study Falko Tesch, Franz Ehm, Annika Vivirito, Danny Wende, Manuel Batram, Friedrich Loser, et al. (+18)
8 [GO] 2023―Jun―04 Cogan syndrome following SARS-COV-2 infection Longfang Chen, Jialin Teng, Chengde Yang, Huihui Chi
9 [GO] 2023―May―27 Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases E. Oliosi, A. Flahault, C. Charre, D. Veyer, A. Combier, E. Lafont, et al. (+5)
10 [GO] 2023―May―17 Systemic lupus erythematosus nephritis and COVID-19 disease C. Gayathri, K. Monica, P. Aishwarya Lakshmi, S. Mathini, N. Prasanna Kumar, V. Siva Kumar
11 [GO] 2023―Apr―06 Exploring the longer-term impact of the COVID-19 pandemic on physical and mental health of people with inflammatory rheumatic diseases: a cross-sectional survey Samantha Hider, Sara Muller, Lauren Gray, Fay Manning, Mike Brooks, Dominic Heining, et al. (+6)
12 [GO] 2023―Mar―09 COVID-19 information uptake amongst a rheumatology interested population Steven J. Katz, Jill J. Hall
13 [GO] 2023―Mar―06 Susac syndrome following COVID-19 vaccination: a case-based review Lior Fisher, Paula David, Tamer Sobeh, Roberta Bisker Liberman, Howard Amital
14 [GO] 2023―Jan―25 Hydroxychloroquine: is there a role in long COVID? Samuel S. Y. Wang, Chuanhui Xu
15 [GO] 2023―Jan―19 Predictors of low spike antibody response in patients with systemic rheumatic disease after an initial course of COVID-19 vaccination Mary Grace Whelan, Leah Santacroce, Lucy Masto, Grace Qian, Emily Kowalski, Kathleen Vanni, et al. (+4)
16 [GO] 2023―Jan―13 Outcomes of Filipinos with inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspective Geraldine Tong Zamora-Abrahan, Evelyn Osio Salido, Juan Javier Tayengco Lichauco, Anna Kristina Manahan Gutierrez-Rubio, Ivy Catherine Talavera Rivera-Go, Karen Joy Castañeda Cortez, et al. (+3)
17 [GO] 2023―Jan―13 Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID) Abdulsamet Erden, Gizem Ayan, Levent Kilic, Dilek Solmaz, Sibel Bakirci, Gezmis Kimyon, et al. (+24)
18 [GO] 2023―Jan―11 Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic Dionicio A. Galarza-Delgado, Jose R. Azpiri-Lopez, Iris J. Colunga-Pedraza, Jesus Alberto Cardenas-de la Garza, Valeria Gonzalez-Gonzalez, Victor M. Beltran-Aguilar, et al. (+3)
19 [GO] 2023―Jan―09 SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis Wojciech Płazak, Leszek Drabik
20 [GO] 2022―Nov―22 Physicians’ perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic Akerke Auanassova, Marlen Yessirkepov, Olena Zimba, Armen Yuri Gasparyan, Mrudula Joshi, Vikas Agarwal, et al. (+2)
21 [GO] 2022―Oct―06 Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry Carolina A. Isnardi, Karen Roberts, Verónica Saurit, Ingrid Petkovic, Roberto M. Báez, Rosana Quintana, et al. (+192)
22 [GO] 2022―Sep―09 Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses Pankti Mehta, Armen Yuri Gasparyan, Olena Zimba, George D. Kitas, Marlen Yessirkepov
23 [GO] 2022―Aug―16 Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry Mari Kihara, Takahiko Sugihara, Junichi Asano, Midori Sato, Hiroshi Kaneko, Sei Muraoka, et al. (+2)
24 [GO] 2022―Aug―15 Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis Arne Schäfer, Magdolna Szilvia Kovacs, Anna Eder, Axel Nigg, Martin Feuchtenberger
25 [GO] 2022―Jul―13 Social networks as education strategies for indigenous patients with rheumatoid arthritis during COVID-19 pandemic. Are they useful? Rosana Quintana, Sofia Fernandez, Lourdes Guggia, Martina Fay, Cecilia Camacho, Graciela Gomez, et al. (+8)
26 [GO] 2022―Jul―08 The relationship between COVID-19 and fibromyalgia syndrome: prevalence, pandemic effects, symptom mechanisms, and COVID-19 vaccines Burhan Fatih Kocyigit, Ahmet Akyol
27 [GO] 2022―Jul―07 Revisiting reactive arthritis during the COVID-19 pandemic Dana Bekaryssova, Marlen Yessirkepov, Olena Zimba, Armen Yuri Gasparyan, Sakir Ahmed
28 [GO] 2022―Jul―05 Perception of risk and impact of the COVID-19 pandemic on patients with rheumatic diseases: a case-control study Alfonso Gastelum-Strozzi, Virginia Pascual, Adolfo Hernández-Garduño, José Francisco Moctezuma-Rios, Guillermo Arturo Guaracha-Basañez, Thalya Sotelo, et al. (+5)
29 [GO] 2022―Jun―28 An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data Carolina A. Isnardi, Emilce E. Schneeberger, Jennifer L. Kreimer, Paula C. Luna, Cristina Echeverría, Karen Roberts, et al. (+26)
30 [GO] 2022―Jun―15 COVID-19 quarantine in adolescents with autoimmune rheumatic diseases: mental health issues and life conditions Bianca P. Ihara, Lívia M. Lindoso, Debora N. D. Setoue, Nicolas Y. Tanigava, Alberto C. Helito, Juliana R. Simon, et al. (+15)
31 [GO] 2022―May―31 Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management Pankti Mehta, Armen Yuri Gasparyan, Olena Zimba, George D. Kitas
32 [GO] 2022―May―25 Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis Chiara Pellicano, Roberta Campagna, Alessandra Oliva, Giorgia Leodori, Marzia Miglionico, Amalia Colalillo, et al. (+4)
33 [GO] 2022―May―25 Clinical evolution of antisynthetase syndrome after SARS-CoV2 infection: a 6-month follow-up analysis Valentina Vertui, Giovanni Zanframundo, Santos Castañeda, Alessandro Biglia, Bianca Lucia Palermo, Ilaria Cavazzana, et al. (+2)
34 [GO] 2022―May―20 Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City Medha Barbhaiya, Marianna B. Frey, Jonah Levine, Gregory Vitone, Lindsay Lally, Michael D. Lockshin, et al. (+3)
35 [GO] 2022―May―14 Patients with idiopathic inflammatory myopathies suffer from worse self-reported PROMIS physical function after COVID-19 infection: an interview-based study from the MyoCite cohort Rajat Kharbanda, Keya Ganatra, Maryam Abbasi, Vikas Agarwal, Latika Gupta
36 [GO] 2022―May―05 Factors affecting patient satisfaction with outpatient rheumatology phone visits during the COVID-19 pandemic Hart A. Goldhar, Ummugulsum Gazel, Catherine Ivory, Nancy Maltez, Susan Humphrey-Murto, Nataliya Milman, Sibel Zehra Aydin
37 [GO] 2022―May―02 Different systemic rheumatic diseases as risk factors for COVID-19-related mortality George E. Fragoulis, Vasiliki-Kalliopi Bournia, Petros P. Sfikakis
38 [GO] 2022―Apr―30 Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases-cross-sectional study from a reference centre in Spain Clara Udaondo, Claudia Millán-Longo, Celia Permuy, Laura Valladares, Iker Falces-Romero, Celia Muñoz-Gómez, et al. (+5)
39 [GO] 2022―Apr―02 COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia Jelka Kramarič, Rok Ješe, Matija Tomšič, Žiga Rotar, Alojzija Hočevar
40 [GO] 2022―Mar―30 Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis Feier Wang, Yubo Ma, Shanshan Xu, Huanhuan Liu, Yuting Chen, Hui Yang, et al. (+7)
41 [GO] 2022―Mar―19 Inactivated SARS-CoV-2 vaccine in primary Sjögren’s syndrome: humoral response, safety, and effects on disease activity Sandra Gofinet Pasoto, Ari Stiel Radu Halpern, Lissiane Karine Noronha Guedes, Ana Cristina Medeiros Ribeiro, Emily Neves Figueiredo Yuki, Carla Gonçalves Schahin Saad, et al. (+13)
42 [GO] 2022―Mar―16 Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report Chantal Lemoine, Cristina Padilla, Noah Krampe, Sean Doerfler, Adam Morgenlander, Brent Thiel, Rohit Aggarwal
43 [GO] 2022―Mar―05 Reactive arthritis before and after the onset of the COVID-19 pandemic Dana Bekaryssova, Marlen Yessirkepov, Olena Zimba, Armen Yuri Gasparyan, Sakir Ahmed
44 [GO] 2022―Feb―19 Flare of adult-onset Still’s disease following mRNA COVID-19 vaccination: a case report and review of literature Ji-Won Kim, Ju-Yang Jung, Chang-Hee Suh, Hyoun-Ah Kim
45 [GO] 2022―Feb―17 Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review Alrashdi Mousa N, Alanazi Majed Saleh, Almoaqly Khalid, Abdulrahman Khaled Alshaya, Sultan Mahja Marzouq Alanazi
46 [GO] 2022―Feb―16 Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China Geyao Qi, Hao Wang, Yufeng Guo, Chi Peng, Chenxu Zhang, Ting Chen, et al. (+2)
47 [GO] 2022―Feb―11 Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity? Alexandros A. Drosos, Eleftherios Pelechas, Paraskevi V. Voulgari
48 [GO] 2022―Feb―03 New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword? Ana M. Anzola, Laura Trives, Julia Martínez-Barrio, Blanca Pinilla, José María Álvaro-Gracia, Juan Molina-Collada
49 [GO] 2022―Jan―29 Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases Francesco Ursini, Piero Ruscitti, Vincenzo Raimondo, Rossella De Angelis, Fabio Cacciapaglia, Erika Pigatto, et al. (+28)
50 [GO] 2022―Jan―27 COVID-19 vaccination outcomes among patients with dermatomyositis: a multicentered analysis Haig Pakhchanian, Ahmad Saud, Rahul Raiker, Sinan Kardes, Rohit Aggarwal, Latika Gupta
51 [GO] 2022―Jan―19 Asymptomatic SARS-CoV-2 seropositivity: patients with childhood-onset rheumatic diseases versus healthy children Fatih Haslak, Dogukan Ozbey, Mehmet Yildiz, Amra Adrovic, Sezgin Sahin, Oya Koker, et al. (+7)
52 [GO] 2022―Jan―18 New-onset Adult-onset Still’s disease-like syndrome after ChAdOx1 nCoV-19 vaccination-a case series with review of literature Shivraj Padiyar, Navaneeth Kamath, John Mathew, A. S. Chandu, Divya Deodhar, B. A. Shastry, et al. (+2)
53 [GO] 2021―Nov―30 Long COVID from rheumatology perspective - a narrative review Hem Raj Sapkota, Arvind Nune
54 [GO] 2021―Nov―29 Coronavirus disease 2019 in patients with Behcet’s disease: a report of 59 cases in Iran Farhad Shahram, Kamal Esalatmanesh, Alireza Khabbazi, Zahra Rezaieyazdi, Zahra Mirfeizi, Alireza Sadeghi, et al. (+4)
55 [GO] 2021―Nov―27 Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network Rahul Raiker, Haig Pakhchanian, Chengappa Kavadichanda, Latika Gupta, Sinan Kardeş, Sakir Ahmed
56 [GO] 2021―Nov―25 Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement Juan Salvador García-Maturano, David Eduardo Torres-Ordaz, Miguel Mosqueda-Gutiérrez, Citlallyc Gómez-Ruiz, Aarón Vázquez-Mellado, Alicia Tafoya-Amado, et al. (+3)
57 [GO] 2021―Nov―16 Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus Ernesto Zavala-Flores, Jannin Salcedo-Matienzo, Ana Quiroz-Alva, Alfredo Berrocal-Kasay
58 [GO] 2021―Nov―05 The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life Khadija El Aoufy, Maria Ramona Melis, Silvia Bellando Randone, Jelena Blagojevic, Francesca Bartoli, Ginevra Fiori, et al. (+9)
59 [GO] 2021―Oct―30 Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus Medha Barbhaiya, Jonah M. Levine, Caroline H. Siegel, Vivian P. Bykerk, Deanna Jannat-Khah, Lisa A. Mandl
60 [GO] 2021―Oct―29 Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months Fatih Karaarslan, Fulya Demircioğlu Güneri, Sinan Kardeş
61 [GO] 2021―Oct―04 Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination Ian Liang, Sanjay Swaminathan, Adrian Y. S. Lee
62 [GO] 2021―Sep―28 Perceptions and behaviours related to COVID-19 in patients with rheumatoid arthritis: a cross-sectional study Takahiro Itaya, Mie Torii, Motomu Hashimoto, Kazuaki Jindai, Wataru Yamamoto, Kyosuke Tanigawa, et al. (+10)
63 [GO] 2021―Sep―25 COVID-19 among patients with Behçet syndrome in the United States Haig Pakhchanian, Rahul Raiker, Sinan Kardeş
64 [GO] 2021―Sep―25 The presence of rheumatological conditions is not a risk factor of long-term post-COVID symptoms after SARS-CoV-2 infection: a multicenter study César Fernández-de-las-Peñas, José D. Martín-Guerrero, Esperanza Navarro-Pardo, Stella Fuensalida-Novo, María Palacios-Ceña, María Velasco-Arribas, Oscar J. Pellicer-Valero
65 [GO] 2021―Sep―12 Impact of COVID-19 on hospitalization of patients with systemic lupus erythematosus (SLE) Wendy Wan Hui Lee, Yaw Kiet Cheong, Cheng Lay Teh, Sharifah Aishah Wan, Seow Lin Chuah, Benjamin Sachdev Manjit Singh
66 [GO] 2021―Aug―24 Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials Dimitrios Patoulias, Michael Doumas, Christodoulos Papadopoulos, Asterios Karagiannis
67 [GO] 2021―Jul―03 Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic Bogna Grygiel-Górniak
68 [GO] 2021―Jul―03 Depression and anxiety might not be increased during COVID-19 pandemic in patient with axial spondyloarthritis E. Erpek, D. Solmaz, D. Bayraktar, S. Akar
69 [GO] 2021―Jul―02 A bibliometric analysis of rheumatology and COVID-19 researches Ozge Pasin, Tugce Pasin
70 [GO] 2021―Jun―29 Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis Aida Malek Mahdavi, Mojtaba Varshochi, Mehrzad Hajialilo, Saeed Dastgiri, Raha Khabbazi, Alireza Khabbazi
71 [GO] 2021―Jun―29 Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up Rocío-V. Gamboa-Cárdenas, Silvia Barzola-Cerrón, Denisse Toledo-Neira, Cristina Reátegui-Sokolova, Víctor Pimentel-Quiroz, Francisco Zevallos-Miranda, et al. (+2)
72 [GO] 2021―Jun―25 Isolated “puffy hands” following COVID-19: clue to a long-term capillary leakage syndrome? Jacopo Ciaffi, Riccardo Meliconi, Piero Ruscitti, Annamaria Iagnocco, Clodoveo Ferri, Roberto Giacomelli, Francesco Ursini
73 [GO] 2021―Jun―22 Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease Padmanabha Shenoy, Sakir Ahmed, K. C. Shanoj, Veena Shenoy, Deepak Damodaran, Aparna R. Menon, et al. (+3)
74 [GO] 2021―Jun―05 Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children Fatih Haslak, Kenan Barut, Cansu Durak, Ayten Aliyeva, Mehmet Yildiz, Vafa Guliyeva, et al. (+15)
75 [GO] 2021―May―29 Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs Behnaz Yousefghahari, Sanaz Navari, Mahmoud Sadeghi, Shima Soleimaniamiri, Mohammadjafar Soleimaniamiri, Behzad Heidari, et al. (+4)
76 [GO] 2021―May―28 Rheumatology and psychiatry: allies in times of COVID-19 Claudia Elera-Fitzcarrald, Jeff Huarcaya-Victoria, Graciela S. Alarcón, Manuel F. Ugarte-Gil
77 [GO] 2021―Apr―29 Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis Jackie Sim, Cynthia Ciwei Lim
78 [GO] 2021―Apr―07 Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19? Diana Castillo-Martínez, Zaira Torres, Luis M. Amezcua-Guerra, Carlos Pineda
79 [GO] 2021―Mar―22 A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review Mehmet Soy, Gökhan Keser, Pamir Atagunduz, Melek Yalçin Mutlu, Alper Gunduz, Gizem Koybaşi, Cemal Bes
80 [GO] 2021―Mar―19 Correction to: Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean Yasemin Ozsurekci, Sibel Gürlevik, Selman Kesici, Ummusen Kaya Akca, Pembe Derin Oygar, Kubra Aykac, et al. (+13)
81 [GO] 2021―Mar―17 COVID-19 and the clinical course of rheumatic manifestations Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
82 [GO] 2021―Mar―06 The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia Gerard Espinosa, Sergio Prieto-González, Mireia Llevadot, Javier Marco-Hernández, Antonio Martínez-Artuña, Albert Pérez-Isidro, et al. (+2)
83 [GO] 2021―Feb―12 Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean Yasemin Ozsurekci, Sibel Gürlevik, Selman Kesici, Ummusen Kaya Akca, Pembe Derin Oygar, Kubra Aykac, et al. (+12)
84 [GO] 2021―Jan―25 Impact of COVID-19 on rheumatology practice in the UK-a pan-regional rheumatology survey Arvind Nune, Karthikeyan P. Iyengar, Ashar Ahmed, Syed Bilgrami, Hem Raj Sapkota
85 [GO] 2021―Jan―19 Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies Antonio Cristiano, Valentina Fortunati, Fabio Cherubini, Sergio Bernardini, Marzia Nuccetelli
86 [GO] 2021―Jan―15 Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice? Lucie Pothen, Halil Yildiz, Mathilde Mbouck Samnick, Jean Cyr Yombi
87 [GO] 2021―Jan―11 Superior mesenteric artery syndrome in a patient with rheumatoid arthritis and rheumatoid cachexia during the COVID-19 pandemic Dionicio Ángel Galarza-Delgado, Diana Elsa Flores-Alvarado, Jesús Eduardo Compeán-Villegas
88 [GO] 2021―Jan―11 Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic Steffen Springer, Artur Strzelecki, Michael Zieger
89 [GO] 2021―Jan―11 COVID-19 vaccination in immunocompromised patients Bhavin Sonani, Fawad Aslam, Amandeep Goyal, Janki Patel, Pankaj Bansal
90 [GO] 2021―Jan―09 Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population Timothy Arleo, David Tong, Julie Shabto, Ghazala O’Keefe, Arezou Khosroshahi
91 [GO] 2021―Jan―07 COVID-19, rheumatic diseases and immune dysregulation-a perspective Shahna Tariq, Charmaine Van Eeden, Jan Willem Cohen Tervaert, Mohammed S. Osman
92 [GO] 2021―Jan―03 Haemophagocytic syndrome and COVID-19 Soledad Retamozo, Pilar Brito-Zerón, Antoni Sisó-Almirall, Alejandra Flores-Chávez, María-José Soto-Cárdenas, Manuel Ramos-Casals
93 [GO] 2020―Nov―24 Characteristics and evolution of 38 patients with rheumatic diseases and COVID-19 under DMARD therapy Dionicio Ángel Galarza-Delgado, Griselda Serna-Peña, Jesús Eduardo Compeán-Villegas, Jesus Alberto Cardenas-de la Garza, Rita Angélica Pineda-Sic, Iris Jazmín Colunga-Pedraza, et al. (+4)
94 [GO] 2020―Nov―20 COVID-19 in rheumatoid arthritis cases: an Iranian referral center experience Soraya Shadmanfar, Nematollah Jonaidi-Jafari, Ramezan Jafari, Zeynab Rastgar-Moqaddam, Amin Saburi
95 [GO] 2020―Nov―14 COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort Greta Pellegrino, Davide Mohammad Reza Beigi, Carlotta Angelelli, Katia Stefanantoni, Marius Cadar, Silvia Mancuso, et al. (+2)
96 [GO] 2020―Nov―11 Incidence of COVID-19 in patients with rheumatic disease: is prior health education more important than shielding advice during the pandemic? Sarah Kipps, Anindita Paul, Sreekanth Vasireddy
97 [GO] 2020―Oct―31 Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends Sinan Kardeş, Ali Suat Kuzu, Haig Pakhchanian, Rahul Raiker, Mine Karagülle
98 [GO] 2020―Oct―19 Diversifying online rheumatology education options in the era of COVID-19 Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
99 [GO] 2020―Oct―16 Challenges, collaboration, and innovation in rheumatology education during the COVID-19 pandemic: leveraging new ways to teach Anisha B Dua, Adam Kilian, Rebecca Grainger, Sarah A Fantus, Zachary S Wallace, Frank Buttgereit, Beth L Jonas
100 [GO] 2020―Oct―04 Biologics in systemic autoimmune diseases during COVID-19 pandemic Narender Annapureddy, Krishna Nalleballe, Sanjeeva Reddy Onteddu, Rohan Sharma, Sen Sheng, Sukanthi Kovvuru, et al. (+2)
101 [GO] 2020―Sep―29 The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study Nelly Ziadé, Ihsane Hmamouchi, Lina el Kibbi, Nizar Abdulateef, Hussein Halabi, Fatemah Abutiban, et al. (+4)
102 [GO] 2020―Sep―26 Living with arthritis: a “training camp” for coping with stressful events? A survey on resilience of arthritis patients following the COVID-19 pandemic Jacopo Ciaffi, Veronica Brusi, Lucia Lisi, Luana Mancarella, Martina D’Onghia, Elisabetta Quaranta, et al. (+7)
103 [GO] 2020―Sep―26 COVID-19 reinfection or relapse: an intriguing dilemma Manu Madan, Shekhar Kunal
104 [GO] 2020―Sep―24 Clinical impact of COVID-19 on a French population of spondyloarthritis patients Christian Hubert Roux, O. Brocq, F. Gerald, C. Pradier, L. Bailly
105 [GO] 2020―Sep―17 Moving towards online rheumatology education in the era of COVID-19 Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
106 [GO] 2020―Sep―08 Managing rheumatic diseases during COVID-19 Amit P. Ladani, Muruga Loganathan, Abhijeet Danve
107 [GO] 2020―Sep―06 Managing rheumatoid arthritis during COVID-19 Rashmi Roongta, Alakendu Ghosh
108 [GO] 2020―Sep―05 Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients? Jorge Morales-Torres, Francisco Javier Aceves-Ávila
109 [GO] 2020―Sep―03 The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach Sahar Najafi, Elham Rajaei, Rezvan Moallemian, Forough Nokhostin
110 [GO] 2020―Sep―02 African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic Richard Oluyinka Akintayo, Rachid Bahiri, Yasser El Miedany, Hakeem Olaosebikan, Asgar Ali Kalla, Adewale Olukayode Adebajo, et al. (+19)
111 [GO] 2020―Aug―27 COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Massimo L’Andolina, Antonio Tavoni, Riccardo Cecchetti, et al. (+22)
112 [GO] 2020―Aug―25 High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review Hiroyuki Fujii, Taisuke Tsuji, Tatsuya Yuba, Shunya Tanaka, Yoshifumi Suga, Aosa Matsuyama, et al. (+6)
113 [GO] 2020―Aug―15 Virtual rheumatology appointments during the COVID-19 pandemic: an international survey of perspectives of patients with rheumatic diseases Alyssa Howren, J. Antonio Aviña-Zubieta, Nevena Rebić, Hallie Dau, Louise Gastonguay, Kam Shojania, et al. (+2)
114 [GO] 2020―Jul―28 Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review Feng He, Qingqing Luo, Ming Lei, Lixin Fan, Xinning Shao, Kaiyuan Hu, et al. (+4)
115 [GO] 2020―Jul―27 Determinants of COVID-19 disease severity in patients with underlying rheumatic disease C. Sieiro Santos, C. Moriano Morales, E. Díez Álvarez, C. Álvarez Castro, A. López Robles, T. Perez Sandoval
116 [GO] 2020―Jul―27 Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology Eduardo Mantovani Cardoso, Jasmin Hundal, Dominique Feterman, John Magaldi
117 [GO] 2020―Jul―25 Challenges in delivering rheumatology care during COVID-19 pandemic A. Nune, K. Iyengar, A. Ahmed, H. Sapkota
118 [GO] 2020―Jul―11 Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad Sakir Ahmed, Olena Zimba, Armen Yuri Gasparyan
119 [GO] 2020―Jun―20 Comment on “Colchicine may not be effective in COVID-19 infection; it may even be harmful?” Senol Kobak
120 [GO] 2020―Jun―20 The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al. Silvia Piantoni, Enrico Colombo, Paolo Airò, Angela Tincani, Antonio Brucato, Franco Franceschini, et al. (+3)
121 [GO] 2020―Jun―19 A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab Shaozhe Cai, Wei Sun, Ming Li, Lingli Dong
122 [GO] 2020―Jun―18 Colchicine as a possible therapeutic option in COVID-19 infection Rafael Parra-Medina, Juan Camilo Sarmiento-Monroy, Adriana Rojas-Villarraga, Edgar Garavito, Giovanni Montealegre-Gómez, Arley Gómez-López
123 [GO] 2020―Jun―17 Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19 Carmine Gazzaruso, Nicoletta Carlo Stella, Giuseppe Mariani, Anna Tamburlini, Pietro Garini, Elena Freddi, et al. (+3)
124 [GO] 2020―Jun―17 COVID-19 and Kawasaki disease: an analysis using Google Trends Mrinalini Dey, Sizheng Steven Zhao
125 [GO] 2020―Jun―08 The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress Martina Orlandi, Gemma Lepri, Cosimo Bruni, Yukai Wang, Alessandro Bartoloni, Lorenzo Zammarchi, et al. (+4)
126 [GO] 2020―Jun―04 Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2 C. Sieiro Santos, C. Nogal Arias, C. Moriano Morales, M. Ballesteros Pomar, E. Diez Alvarez, T. Perez Sandoval
127 [GO] 2020―Jun―03 Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? Sebastián Ibáñez, Oriela Martínez, Francisca Valenzuela, Francisco Silva, Omar Valenzuela
128 [GO] 2020―May―30 Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India Padmanabha Shenoy, Sakir Ahmed, Aby Paul, Teny Grace Skaria, Joel Joby, Bazil Alias
129 [GO] 2020―May―30 Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment Mehmet Soy, Gökhan Keser, Pamir Atagündüz, Fehmi Tabak, Işık Atagündüz, Servet Kayhan
130 [GO] 2020―May―30 Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? Kiana Vakil-Gilani, Kenneth O’Rourke
131 [GO] 2020―May―29 COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments Dieu-Donné Ouédraogo, Wendlassida Joelle Stéphanie Tiendrébéogo, Fulgence Kaboré, Honoré Ntsiba
132 [GO] 2020―May―29 Treatment algorithm for COVID-19: a multidisciplinary point of view Felice Galluccio, Tolga Ergonenc, Alvaro Garcia Martos, Abdallah El-Sayed Allam, Maria Pérez-Herrero, Ricardo Aguilar, et al. (+4)
133 [GO] 2020―May―27 Navigating COVID-19 in the developing world Bridget Hodkinson, Prasun Singh, Ayanda Gcelu, Wilson Bautista Molano, Guillermo Pons-Estel, Deshiré Alpízar-Rodríguez
134 [GO] 2020―May―27 Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity Antonina Minniti, Wanda Maglione, Francesca Pignataro, Carmela Cappadona, Roberto Caporali, Nicoletta Del Papa
135 [GO] 2020―May―27 High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia Carmine Gazzaruso, Nicoletta Carlo Stella, Giuseppe Mariani, Carlo Nai, Adriana Coppola, Daniela Naldani, Pietro Gallotti
136 [GO] 2020―May―26 Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis Adem Kucuk, Medine Cumhur Cure, Erkan Cure
137 [GO] 2020―May―25 Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review Jinghong Dai, Yali Xiong, Hui Li, Yajun Qian, Ying Xu, Qingqing Xu, et al. (+2)
138 [GO] 2020―May―23 YouTube as a source of information on COVID-19 and rheumatic disease link Burhan Fatih Kocyigit, Mazlum Serdar Akaltun, Ahmet Riza Sahin
139 [GO] 2020―May―14 COVID-19 with rheumatic diseases: a report of 5 cases Chuanfang Cheng, Chuanjing Li, Tao Zhao, Jing Yue, Fang Yang, Yimin Yan, Xiaoan Liu
140 [GO] 2020―May―11 Colchicine may not be effective in COVID-19 infection; it may even be harmful? Medine Cumhur Cure, Adem Kucuk, Erkan Cure
141 [GO] 2020―May―09 Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? Sakir Ahmed, Prajna Anirvan
142 [GO] 2020―May―09 How should we overcome the threat by the pandemic of 2019-nCoV? Epidemic simulation using the SIRS model Jun Inamo
143 [GO] 2020―Apr―10 Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets Durga Prasanna Misra, Vikas Agarwal, Armen Yuri Gasparyan, Olena Zimba
 [1] 

143 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec